Muraoka S, Shulman M J
Department of Immunology, University of Toronto, Canada.
J Immunol. 1989 Jan 15;142(2):695-701.
Glycosylation of IgG occurs at asparagine 297 of the gamma H chain and is necessary for the normal capacity of IgG to activate the classical pathway of complement-dependent cytolysis. IgM is glycosylated at five sites in the constant region of the mu H chain, of which glycosylation at asparagine 402 seems analogous to the glycosylation of IgG. In order to assess the importance of glycosylation at asparagine 402 for IgM cytolytic activity, we have used site-directed mutagenesis to produce IgM which is not glycosylated at this position. In particular we have tested the effects of substituting Gln for Asn 402 and Thr-Gly for Gly 403-Thr 404 in the third constant region domain. We tested the effects of these substitutions by expressing the mutant mu genes in hybridoma cells which produce the hapten-specific kappa-chain. The normal mu-chain is glycosylated at Asn 402, and, as expected, these mutations appear to abrogate glycosylation of the mutant mu-chains at position 402 and do not affect the hapten affinity of the IgM. However, both of these mutations cause the increased production of monomeric rather than polymeric IgM: the ratio of monomeric to polymeric IgM is 0.21, 3.5, and 10.3 for wild-type IgM, IgM-Gln 402, and IgM-Thr 403-Gly 404, respectively. The wild-type and mutant polymeric IgM preparations were compared for their capacity to promote complement-dependent cytolysis: IgM-Gln 402 and IgM-Thr 403-Gly 404 have approximately 31% and 4%, respectively, of the capacity of wild-type IgM.
IgG的糖基化发生在γ重链的天冬酰胺297位,这对于IgG激活补体依赖性细胞溶解经典途径的正常能力是必需的。IgM在μ重链恒定区的五个位点进行糖基化,其中天冬酰胺402位的糖基化似乎与IgG的糖基化类似。为了评估天冬酰胺402位糖基化对IgM细胞溶解活性的重要性,我们使用定点诱变来产生在此位置未糖基化的IgM。特别是,我们测试了用谷氨酰胺替代天冬酰胺402以及用苏氨酸-甘氨酸替代第三恒定区结构域中的甘氨酸403-苏氨酸404的效果。我们通过在产生半抗原特异性κ链的杂交瘤细胞中表达突变的μ基因来测试这些替代的效果。正常的μ链在天冬酰胺402位进行糖基化,正如预期的那样,这些突变似乎消除了突变μ链在402位的糖基化,并且不影响IgM对半抗原的亲和力。然而,这两种突变都导致单体而非多聚体IgM的产生增加:野生型IgM、IgM-谷氨酰胺402和IgM-苏氨酸403-甘氨酸404的单体与多聚体IgM的比例分别为0.21、3.5和10.3。比较了野生型和突变型多聚体IgM制剂促进补体依赖性细胞溶解的能力:IgM-谷氨酰胺402和IgM-苏氨酸403-甘氨酸404分别具有野生型IgM能力的约31%和4%。